WordNet

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 過敏性腸症候群に対するアロセトロン塩酸塩（Lotronex） alosetron hydrochloride lotronex for irritable bowel syndrome
2. アレルギー性結膜炎：マネージメント allergic conjunctivitis management
3. 変形性膝関節症のマネージメント management of knee osteoarthritis
4. 成人における急性咽頭炎の対症療法 symptomatic treatment of acute pharyngitis in adults
5. 黄菌毛症 trichomycosis trichobacteriosis

Automated on-line in-tube solid-phase microextraction coupled with HPLC/MS/MS for the determination of butyrophenone derivatives in human plasma.

Kumazawa T1, Saeki K, Yanagisawa I, Uchigasaki S, Hasegawa C, Seno H, Suzuki O, Sato K.
Analytical and bioanalytical chemistry.Anal Bioanal Chem.2009 Jun;394(4):1161-70. doi: 10.1007/s00216-009-2774-0. Epub 2009 Apr 23.
This paper describes a fully automated on-line method combining in-tube solid-phase microextraction (SPME) in which sample clean-up and enrichment are conducted through an open tubular fused-silica capillary column and high-performance liquid chromatography (HPLC)/tandem mass spectrometry (MS/MS) de
PMID 19387622

Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain.

Oka T1, Hamamura T, Lee Y, Miyata S, Habara T, Endo S, Taoka H, Kuroda S.
Life sciences.Life Sci.2004 Nov 26;76(2):225-37.
Acute administration of typical and atypical antipsychotics has been reported to induce regionally distinct patterns of c-Fos expression in the rat forebrain. Furthermore, atypical index, the difference in the extent of increased Fos-like immunoreactivity (Fos-LI) in the nucleus accumbens (NAc) shel
PMID 15519367

High-performance liquid chromatographic determination of fluvoxamine and fluvoxamino acid in human plasma.

Ohkubo T1, Shimoyama R, Otani K, Yoshida K, Higuchi H, Shimizu T.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.Anal Sci.2003 Jun;19(6):859-64.
A high-performance liquid chromatographic (HPLC) method has been developed for the simultaneous determination of fluvoxamine and its major metabolite fluvoxamino acid in plasma. Fluvoxamine and fluvoxamino acid in plasma were extracted using a C18 bonded-solid phase cartridge, followed by C4 reverse
PMID 12834224